Wave Life Sciences (WVE) Accumulated Expenses (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Accumulated Expenses data on file, last reported at $5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 23.77% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 23.77% YoY), and the FY2025 full-year result was $1.2 million, down 74.29% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $5.5 million, up from $1.2 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $17.6 million in Q4 2022 and bottomed at $1.0 million in Q2 2022.
• The 5-year median for Accumulated Expenses is $4.6 million (2024), against an average of $6.7 million.
• The widest annual swing landed in 2022, when Accumulated Expenses tumbled 82.85%; it then jumped 1000.61% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $17.6 million in 2022, then slipped by 4.12% to $16.8 million in 2023, then slumped by 72.96% to $4.6 million in 2024, then plunged by 74.29% to $1.2 million in 2025, then jumped by 371.71% to $5.5 million in 2026.
• The last three Accumulated Expenses figures came in at $5.5 million (Q1 2026), $1.2 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.

Peer Comparison